证券代码：605077 证券简称：华康股份 公告编号：2026-008 债券代码：111018 债券简称：华康转债 浙江华康药业股份有限公司 关于注销向不特定对象发行可转换公司债券 募集资金专项账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、2023年向不特定对象发行可转换公司债券募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江华康药业股份有限公司向不特定对象发行可转换公司债券 注册的批复》（证监许可〔2023〕2739号），本公司由主承销商东方证券承销保荐有限公司向不特定对 象发行可转换公司债券13,030,230张，每张面值为人民币100.00元，按面值发行，发行总额为人民币 130,302.30万元，共计募集资金130,302.30万元，扣除本次发行费用963.77万元后，公司本次募集资金净 额为129,338.53万元。上述募集资金到位情况业经天健会计师事务所（特殊普通合伙）验证，并由其出 具《验资报告》（天健验〔2023〕755号）。 二、2023年向不特定对象发行可转换公司债券募集资 ...

[Table_StockNam基eRp础tTyp化e] 工 行业周报 合成生物学周报：工信部公布 35 例非粮生物基材料，阿洛酮糖 应用有望迎来爆发 报告日期： 2026-02-10 公司价格与沪深 300 走势比较 相关报告 2026-02-02 执业证书号：S0010522110002 电话：13621792701 邮箱：wangqf@hazq.com 分析师：潘宁馨 执业证书号：S0010524070002 电话：13816562460 邮箱：pannx@hazq.com 行业评级： 增持 主要观点： [T行ab业le_周Su观m点mary] 华安证券化工团队发表的《合成生物学周报》是一份面向一级市 场、二级市场，汇总国内外合成生物学相关领域企业信息的行业周报。 目前生命科学基础前沿研究持续活跃，生物技术革命浪潮席卷全 球并加速融入经济社会发展，为人类应对生命健康、气候变化、资源 能源安全、粮食安全等重大挑战提供了崭新的解决方案。国家发改委 印发《"十四五"生物经济发展规划》,生物经济万亿赛道呼之欲出。 分析师：王强峰 合成生物学指数是华安证券研究所根据上市公司公告等汇总整 理由 60 家业务涉及合成生 ...

| 证券代码：605077 | 证券简称：华康股份 | 公告编号：2026-008 | | --- | --- | --- | | 债券代码：111018 | 债券简称：华康转债 | | 浙江华康药业股份有限公司 关于注销向不特定对象发行可转换公司债券 募集资金专项账户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、2023 年向不特定对象发行可转换公司债券募集资金基本情况 三、2023 年向不特定对象发行可转换公司债券募集资金专户销户情况 根据《管理办法》，本公司对募集资金实行专户存储，在银行设立募集资金 专户，并连同保荐机构东方证券承销保荐有限公司于 2023 年 12 月分别与招商银 行股份有限公司衢州分行、中国银行股份有限公司开化华埠支行、中国建设银行 股份有限公司开化支行、中信银行股份有限公司衢州分行签订了《募集资金专户 存储三方监管协议》，本公司及子公司舟山华康生物科技有限公司连同保荐机构 东方证券承销保荐有限公司于 2023 年 12 月分别与招商银行股份有限公司衢州分 行、中国建设银行股份有限 ...

Core Viewpoint - Huakang Co., Ltd. is progressing with its "1 million tons corn deep processing health food ingredient project," which is expected to improve operational performance as production stabilizes and efficiency optimizes [1]. Group 1: Project Overview - The project will begin phased production starting from the third year, with production loads reaching 50% in the first year, 70% in the second year, and 100% from the third year onward [1]. - The primary goal of the project is to secure the supply of key raw materials, enhance existing product capacity, and meet diverse customer product demands [1]. Group 2: Product Development - The company plans to utilize corn as a raw material to produce a series of deep-processed products, including starch sugar/sugar alcohol, dietary fiber, and modified starch [1]. - Advanced technologies such as synthetic biology and green manufacturing will be employed to produce various products, including allulose [1].

证券日报网讯1月27日，华康股份（605077）在互动平台回答投资者提问时表示，公司短期借款增加主 要系本期票据贴现借款增加所致；长期借款增加主要系舟山华康项目贷款增加所致。 ...

证券日报网讯1月27日，华康股份（605077）在互动平台回答投资者提问时表示，公司积极与投资者保 持良好沟通，并严格依照相关规定履行信息披露义务，发生的投资者关系活动均会在上证e互动上进行 披露。 ...

Core Viewpoint - Huakang Co., Ltd. (605077) has a strong market presence with its products widely used in food, beverage, pharmaceutical, and daily chemical industries, demonstrating high market recognition [1] Group 1: Market Presence - The company has established long-term cooperative relationships with well-known domestic and international food and beverage enterprises, with products sold in major global markets including Europe, America, and Asia [1] - In the domestic market, the company has built a sales network covering most provinces, cities, and autonomous regions [1] Group 2: Sales Strategy - The company is expanding its domestic e-commerce market through its subsidiary, Huakang Trading, transitioning from a primarily B2B model to a combination of B2B and B2C models, creating a more comprehensive sales system [1]

Core Viewpoint - Huakang Co., Ltd. has established a strong market presence with its products widely used in various downstream industries such as food, beverages, pharmaceuticals, and daily chemicals, indicating high market recognition [2]. Group 1 - The company's products are extensively applied in food, beverage, pharmaceutical, and daily chemical industries [2]. - Huakang has built long-term cooperative relationships with well-known domestic and international companies in the food and beverage sector [2]. - The company's products are sold in major markets globally, including Europe, America, and Asia [2]. Group 2 - The primary sales method for the company is direct sales [2]. - Huakang has established a subsidiary in Europe to enhance its market reach [2].

（文章来源：证券日报） 证券日报网讯 1月27日，华康股份在互动平台回答投资者提问时表示，截至2025年9月30日，公司普通 股股东总数为14122户。 ...

Group 1 - The company is committed to improving its management level and enhancing its internal value to create long-term, stable, and sustainable returns for shareholders [2] - The actual controller and their concerted actions in reducing holdings are part of personal financial planning, indicating confidence in the company's future development [2]